Does transcatheter aortic valve replacement for bicuspid aortic stenosis reduce mortality or stroke in patients with aortic stenosis compared to transcatheter aortic valve replacement for tricuspid aortic stenosis?
TAVR for bicuspid aortic stenosis is associated with similar 1-year mortality but a higher 30-day stroke risk compared to TAVR for tricuspid aortic stenosis.
In this preliminary, registry-based study of propensity-matched patients who had undergone transcatheter aortic valve replacement for aortic stenosis, patients with bicuspid vs tricuspid aortic stenosis had no significant difference in 30-day or 1-year mortality but had increased 30-day risk for stroke. Because of the potential for selection bias and the absence of a control group treated surgically for bicuspid stenosis, randomized trials are needed to adequately assess the efficacy and safety of transcatheter aortic valve replacement for bicuspid aortic stenosis.
Makkar et al. (Tue,) studied this question.